awacke1/LOINC-Clinical-Terminology · Datasets at Hugging Face

LOINC_NUM stringlengths 3 8	COMPONENT stringlengths 2 246	PROPERTY stringlengths 1 29	TIME_ASPCT stringlengths 1 15	SYSTEM stringlengths 1 106	SCALE_TYP stringclasses 10 values	METHOD_TYP stringlengths 1 57 ⌀	CLASS stringlengths 2 24	CLASSTYPE int64 1 4	LONG_COMMON_NAME stringlengths 3 254	SHORTNAME stringlengths 2 51 ⌀	EXTERNAL_COPYRIGHT_NOTICE stringlengths 39 2.6k ⌀	STATUS stringclasses 4 values	VersionFirstReleased stringlengths 1 7	VersionLastChanged stringlengths 1 5
98077-1	Whether the patient previously met the case definition for condition of interest	Find	Pt	^Patient	Ord	null	H&P.HX	2	Whether the patient previously met the case definition for condition of interest	Previous case condition of interest	null	ACTIVE	2.71	2.71
98078-9	Difficulty reading or writing	Find	Pt	^Patient	Ord	null	SURVEY.GNHLTH	4	Difficulty reading or writing	null	null	ACTIVE	2.71	2.71
9807-9	Chlordane	MCnc	Pt	Ser/Plas	Qn	null	DRUG/TOX	1	Chlordane [Mass/volume] in Serum or Plasma	Chlordane SerPl-mCnc	null	ACTIVE	1.0i	2.42
98079-7	Do you need any additional assistance or accommodations during your visit	Find	Pt	^Patient	Ord	null	SURVEY.GNHLTH	4	Do you need any additional assistance or accommodations during your visit	null	null	ACTIVE	2.71	2.71
98080-5	SARS coronavirus 2 & SARS-related coronavirus RNA panel	-	Pt	Saliva	-	Probe.amp.tar	PANEL.MICRO	1	SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Saliva (oral fluid) by NAA with probe detection	SARS-CoV-2+SARSr-CoV RNA pnl Sal NAA+prb	null	ACTIVE	2.71	2.71
98081-3	Cytomegalovirus DNA	NCnc	Pt	Saliva	Qn	Probe.amp.tar	MICRO	1	Cytomegalovirus DNA [#/volume] (viral load) in Saliva (oral fluid) by NAA with probe detection	CMV DNA # Sal NAA+probe	null	ACTIVE	2.71	2.71
98082-1	Specific resistance.airway^pre bronchodilation	FldResist	Stdy^mean	Respiratory system.airway	Qn	Plethysmograph.body box	PULM	2	Specific airway resistance mean by Plethysmograph body box --pre bronchodilation	Spec airway resist pre BD Mean Plethys	null	ACTIVE	2.71	2.71
98083-9	Specific resistance.airway^post bronchodilation	FldResist	Stdy^mean	Respiratory system.airway	Qn	Plethysmograph.body box	PULM	2	Specific airway resistance mean by Plethysmograph body box --post bronchodilation	Spec airway resist p BD Mean Plethys	null	ACTIVE	2.71	2.71
98084-7	Specific effective resistance.airway	FldResist	Stdy^mean	Respiratory system.airway	Qn	Calculated	PULM	2	Specific effective resistance.airway mean Calculated	sReff Mean Calc	null	ACTIVE	2.71	2.71
98085-4	Specific effective resistance.airway^pre bronchodilation	FldResist	Stdy^mean	Respiratory system.airway	Qn	Calculated	PULM	2	Specific effective resistance.airway mean Calculated --pre bronchodilation	sReff pre BD Mean Calc	null	ACTIVE	2.71	2.71
98086-2	Specific effective resistance.airway^post bronchodilation	FldResist	Stdy^mean	Respiratory system.airway	Qn	Calculated	PULM	2	Specific effective resistance.airway mean Calculated --post bronchodilation	sReff p BD Mean Calc	null	ACTIVE	2.71	2.71
9808-7	Phenothiazines	PrThr	Pt	Gast fld	Ord	null	DRUG/TOX	1	Phenothiazines [Presence] in Gastric fluid	Phenothiaz Gast Ql	null	ACTIVE	1.0i	2.56
98087-0	Specific effective resistance.airway/predicted	RelFldResist	Stdy^mean	Respiratory system.airway	Qn	null	PULM	2	Specific effective resistance.airway/Predicted mean	sReff/Predicted Mean	null	ACTIVE	2.71	2.71
98088-8	Vital capacity/Vital capacity.predicted	RelVol	Pt	Respiratory system	Qn	Spirometry	PULM	2	Vital capacity/predicted VC Respiratory system by Spirometry	VC/predicted VC Respiratory Spirometry	null	ACTIVE	2.71	2.71
98089-6	Capacity.inspiratory^pre bronchodilation	Vol	Pt	Respiratory system	Qn	Spirometry	PULM	2	Inspiratory capacity by Spirometry --pre bronchodilation	IC pre BD Spirometry	null	ACTIVE	2.71	2.71
98090-4	Capacity.inspiratory^post bronchodilation	Vol	Pt	Respiratory system	Qn	Spirometry	PULM	2	Inspiratory capacity by Spirometry --post bronchodilation	IC p BD Spirometry	null	ACTIVE	2.71	2.71
98091-2	Diffusion capacity.carbon monoxide^pre bronchodilation	FldConduct	Pt	Respiratory system	Qn	null	PULM	2	Diffusion capacity.carbon monoxide --pre bronchodilation	Diff cap.CO pre BD	null	ACTIVE	2.71	2.71
98092-0	Diffusion capacity.carbon monoxide^post bronchodilation	FldConduct	Pt	Respiratory system	Qn	null	PULM	2	Diffusion capacity.carbon monoxide --post bronchodilation	Diff cap.CO p BD	null	ACTIVE	2.71	2.71
98093-8	Rowland Universal Dementia Assessment Scale	-	Pt	^Patient	-	RUDAS	PANEL.SURVEY.RUDAS	4	Rowland Universal Dementia Assessment Scale [RUDAS]	null	null	ACTIVE	2.71	2.71
98094-6	Total score	Score	Pt	^Patient	Qn	RUDAS	SURVEY.RUDAS	4	Total score [RUDAS]	null	null	ACTIVE	2.71	2.71
9809-5	Propoxyphene	PrThr	Pt	Gast fld	Ord	null	DRUG/TOX	1	Propoxyphene [Presence] in Gastric fluid	Propoxyph Gast Ql	null	ACTIVE	1.0i	2.56
98095-3	Cells.FOXP3 Ag/100 cells	NFr	Pt	Bld	Qn	null	MICRO	1	Cells.FOXP3 Ag/100 cells in Blood	FOXP3 Ag Bld-NFr	null	ACTIVE	2.71	2.72
98096-1	Interleukin 33	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Interleukin 33 [Mass/volume] in Serum or Plasma	IL-33 SerPl-mCnc	null	ACTIVE	2.71	2.71
98097-9	Thymic stromal lymphopoietin	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Thymic stromal lymphopoietin [Mass/volume] in Serum or Plasma	TSLP SerPl-mCnc	null	ACTIVE	2.71	2.71
98098-7	Interleukin 17F	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Interleukin 17F [Mass/volume] in Serum or Plasma	IL-17F SerPl-mCnc	null	ACTIVE	2.71	2.71
98099-5	Interleukin 21	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Interleukin 21 [Mass/volume] in Serum or Plasma	IL-21 SerPl-mCnc	null	ACTIVE	2.71	2.71
98100-1	Interleukin 22	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Interleukin 22 [Mass/volume] in Serum or Plasma	IL-22 SerPl-mCnc	null	ACTIVE	2.71	2.71
98101-9	Interleukin 23	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Interleukin 23 [Mass/volume] in Serum or Plasma	IL-23 SerPl-mCnc	null	ACTIVE	2.71	2.71
98102-7	Chemokine (C-X-C motif) ligand 10	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Chemokine (C-X-C motif) ligand 10 [Mass/volume] in Serum or Plasma	CXCL10 SerPl-mCnc	null	ACTIVE	2.71	2.71
9810-3	quiNINE	PrThr	Pt	Gast fld	Ord	null	DRUG/TOX	1	quiNINE [Presence] in Gastric fluid	quiNINE Gast Ql	null	ACTIVE	1.0i	2.56
98103-5	Interleukin 9	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Interleukin 9 [Mass/volume] in Serum or Plasma	IL-9 SerPl-mCnc	null	ACTIVE	2.71	2.71
98104-3	Interleukin 15	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Interleukin 15 [Mass/volume] in Serum or Plasma	IL-15 SerPl-mCnc	null	ACTIVE	2.71	2.71
98105-0	Interleukin 16	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Interleukin 16 [Mass/volume] in Serum or Plasma	IL-16 SerPl-mCnc	null	ACTIVE	2.71	2.71
98106-8	Brain-derived neurotrophic factor	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Brain-derived neurotrophic factor [Mass/volume] in Serum or Plasma	BDNF SerPl-mCnc	null	ACTIVE	2.71	2.71
98107-6	Macrophage colony-stimulating factor	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Macrophage colony-stimulating factor [Mass/volume] in Serum or Plasma	M-CSF SerPl-mCnc	null	ACTIVE	2.71	2.71
98108-4	Chemokine (C-C motif) ligand 11	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Chemokine (C-C motif) ligand 11 [Mass/volume] in Serum or Plasma	CCL11 SerPl-mCnc	null	ACTIVE	2.71	2.71
98109-2	Chemokine (C-C motif) ligand 8	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Chemokine (C-C motif) ligand 8 [Mass/volume] in Serum or Plasma	CCL8 SerPl-mCnc	null	ACTIVE	2.71	2.71
981-1	D little i super little a Ab	PrThr	Pt	Ser/Plas	Ord	null	BLDBK	1	Di sup(a) Ab [Presence] in Serum or Plasma	Di sup(a) Ab SerPl Ql	null	ACTIVE	1.0	2.56
98110-0	Chemokine (C-C motif) ligand 7	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Chemokine (C-C motif) ligand 7 [Mass/volume] in Serum or Plasma	CCL7 SerPl-mCnc	null	ACTIVE	2.71	2.71
9811-1	Chromogranin A	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Chromogranin A [Mass/volume] in Serum or Plasma	CgA SerPl-mCnc	null	ACTIVE	1.0i	2.73
98111-8	Chemokine (C-C motif) ligand 4	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Chemokine (C-C motif) ligand 4 [Mass/volume] in Serum or Plasma	CCL4 SerPl-mCnc	null	ACTIVE	2.71	2.71
98112-6	Chemokine (C-C motif) ligand 20	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Chemokine (C-C motif) ligand 20 [Mass/volume] in Serum or Plasma	CCL20 SerPl-mCnc	null	ACTIVE	2.71	2.71
98113-4	Chemokine (C-C motif) ligand 5	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Chemokine (C-C motif) ligand 5 [Mass/volume] in Serum or Plasma	CCL5 SerPl-mCnc	null	ACTIVE	2.71	2.71
98114-2	Chemokine (C-X3-C motif) ligand 1	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Chemokine (C-X3-C motif) ligand 1 [Mass/volume] in Serum or Plasma	CX3CL1 SerPl-mCnc	null	ACTIVE	2.71	2.71
98115-9	Chemokine (C-X-C motif) ligand 9	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Chemokine (C-X-C motif) ligand 9 [Mass/volume] in Serum or Plasma	CXCL9 SerPl-mCnc	null	ACTIVE	2.71	2.71
98116-7	Chemokine (C-C motif) ligand 27	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Chemokine (C-C motif) ligand 27 [Mass/volume] in Serum or Plasma	CCL27 SerPl-mCnc	null	ACTIVE	2.71	2.71
98117-5	Fibroblast growth factor 2	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Fibroblast growth factor 2 [Mass/volume] in Serum or Plasma	FGF2 SerPl-mCnc	null	ACTIVE	2.71	2.71
98118-3	Vascular endothelial growth factor C	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Vascular endothelial growth factor C [Mass/volume] in Serum or Plasma	VEGF-C SerPl-mCnc	null	ACTIVE	2.71	2.71
98119-1	Angiopoietin 2 receptor	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Angiopoietin receptor 2 [Mass/volume] in Serum or Plasma	Angiopoietin 2 receptor SerPl-mCnc	null	ACTIVE	2.71	2.71
98120-9	Intercellular adhesion molecule 1	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Intercellular adhesion molecule 1 [Mass/volume] in Serum or Plasma	ICAM-1 SerPl-mCnc	null	ACTIVE	2.71	2.71
98121-7	Protein/Creatinine	PrThr	Pt	Urine	Ord	Test strip	CHEM	1	Protein/Creatinine Qualitative in Urine by Test strip	Prot/Creat Ur Ql Strip	null	ACTIVE	2.71	2.71
98122-5	Neutrophil.fMLP & PMA stimulated DHR panel	-	Pt	^Patient	-	Flow cytometry	PANEL.HEM/BC	1	Neutrophil.fMLP and PMA stimulated DHR panel by Flow cytometry (FC)	Neut fMLP + PMA stim DHR Pnl Patient FC	null	ACTIVE	2.71	2.72
98123-3	Neutrophil.fMLP stimulated DHR panel	-	Pt	^Patient	-	Flow cytometry	PANEL.HEM/BC	1	Neutrophil.fMLP stimulated DHR panel by Flow cytometry (FC)	Neut fMLP stim DHR Pnl Patient FC	null	ACTIVE	2.71	2.71
98124-1	Neutrophil.PMA stimulated DHR panel	-	Pt	^Patient	-	Flow cytometry	PANEL.HEM/BC	1	Neutrophil.PMA stimulated DHR panel by Flow cytometry (FC)	Neut PMA stim DHR Pnl Patient FC	null	ACTIVE	2.71	2.72
98125-8	Intravascular coagulation and fibrinolysis panel	-	Pt	^Patient	-	null	PANEL.COAG	1	Intravascular coagulation and fibrinolysis panel	Intravascular coag + fibrinolysis Pnl	null	ACTIVE	2.71	2.71
98126-6	Zimnitsky urine concentration panel	-	-	Urine	-	null	PANEL.UA	1	Zimnitsky urine concentration panel - Urine	Zimnitsky Pnl Ur	null	ACTIVE	2.71	2.71
98127-4	Normoblasts.oxyphilic+polychromatophilic/Normoblasts.total	NFr	Pt	Bone mar	Qn	Manual count	HEM/BC	1	Normoblasts oxyphilic+polychromatophilic/Normoblasts.total in Bone marrow by Manual count	Oxy+poly normoblasts/Tot NFr Mar Manual	null	ACTIVE	2.71	2.71
98128-2	Neutrophils.immature/Neutrophils.segmented	Ratio	Pt	Bone mar	Qn	Manual count	HEM/BC	1	Neutrophils.immature/Neutrophils.segmented [Ratio] in Bone marrow by Manual count	Neut.imm/Neut.segment Mar Manual - Rto	null	ACTIVE	2.71	2.71
9812-9	Cortisol^PM trough specimen	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Cortisol [Mass/volume] in Serum or Plasma --PM trough specimen	Cortis PM SerPl-mCnc	null	ACTIVE	1.0i	2.73
98129-0	Thymol turbidity test	Arb	Pt	Bld	Qn	null	CHEM	1	Thymol turbidity test in Blood	Thymol turbidity test Bld	null	ACTIVE	2.71	2.71
98130-8	Diffusion capacity.carbon monoxide/predicted	RelFldConduct	Pt	Respiratory system	Qn	null	PULM	2	Diffusion capacity.carbon monoxide/Predicted	Diff cap.CO/Predicted	null	ACTIVE	2.71	2.71
98131-6	SARS coronavirus 2 ORF1b region	PrThr	Pt	Respiratory	Ord	Probe.amp.tar	MICRO	1	SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory specimen by NAA with probe detection	SARS-CoV-2 ORF1b Resp Ql NAA+probe	null	ACTIVE	2.71	2.71
98132-4	SARS coronavirus 2 ORF1a region	PrThr	Pt	Respiratory	Ord	Probe.amp.tar	MICRO	1	SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory specimen by NAA with probe detection	SARS-CoV-2 ORF1a Resp Ql NAA+probe	null	ACTIVE	2.71	2.71
98133-2	Osteoporosis Index of Risk panel	-	Pt	^Patient	-	Osteoporosis Index of Risk	PANEL.CLIN.RISK	2	Osteoporosis Index of Risk panel	OSIRIS panel	null	ACTIVE	2.71	2.71
98134-0	Estrogen use	Find	Pt	^Patient	Ord	null	H&P.HX	2	Estrogen use	Estrogen use	null	ACTIVE	2.71	2.71
98135-7	Low impact fracture	Hx	Pt	^Patient	Ord	null	H&P.HX	2	History of Low impact fracture	Hx of Low impact fracture	null	ACTIVE	2.71	2.71
98136-5	Total score	Score	Pt	^Patient	Qn	Osteoporosis Index of Risk	CLIN.RISK	2	Total score Osteoporosis Index of Risk	Total score OSIRIS	null	ACTIVE	2.71	2.71
9813-7	Cortisol^AM peak specimen	MCnc	Pt	Ser/Plas	Qn	null	CHEM	1	Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen	Cortis AM peak SerPl-mCnc	null	ACTIVE	1.0i	2.73
98137-3	Pain assessment report	Find	Pt	{Setting}	Doc	{Role}	DOC.ONTOLOGY	2	Pain assessment report	Pain assessment Rpt	null	ACTIVE	2.71	2.71
98138-1	Amyloid plaques probability score	Score	Pt	^Patient	Qn	Based on clinical+lab data	CLIN.RISK	2	Amyloid plaques probability score based on clinical and lab data	Amyloid plaques score from clin+lab data	null	ACTIVE	2.71	2.72
98139-9	Osteoporosis Risk Assessment Instrument	-	Pt	^Patient	-	Osteoporosis Risk Assessment Instrument	PANEL.CLIN.RISK	2	Osteoporosis Risk Assessment Instrument	ORAI	null	ACTIVE	2.71	2.71
98140-7	Total score	Score	Pt	^Patient	Qn	Osteoporosis Risk Assessment Instrument	CLIN.RISK	2	Total score Osteoporosis Risk Assessment Instrument	Total score ORAI	null	ACTIVE	2.71	2.71
98141-5	Admission notification note	Find	Pt	Emergency department	Doc	{Role}	DOC.ONTOLOGY	2	Emergency department Admission notification	ED Admission notification	null	ACTIVE	2.71	2.71
98142-3	Discharge notification note	Find	Pt	Emergency department	Doc	{Role}	DOC.ONTOLOGY	2	Emergency department Discharge notification	ED Discharge notification	null	ACTIVE	2.71	2.71
98143-1	Arrival notification note	Find	Pt	Emergency department	Doc	{Role}	DOC.ONTOLOGY	2	Emergency department Arrival notification	ED Arrival notification	null	ACTIVE	2.71	2.72
98144-9	Departure notification note	Find	Pt	Emergency department	Doc	{Role}	DOC.ONTOLOGY	2	Emergency department Departure notification	ED Departure notification	null	ACTIVE	2.71	2.72
9814-5	Dextroamphetamine	MCnc	Pt	Ser/Plas	Qn	null	DRUG/TOX	1	Dextroamphetamine [Mass/volume] in Serum or Plasma	D-amphet SerPl-mCnc	null	ACTIVE	1.0i	2.73
98145-6	Visit notification note	Find	Pt	Outpatient	Doc	{Role}	DOC.ONTOLOGY	2	Outpatient Visit notification	OP Visit notification	null	ACTIVE	2.71	2.71
98146-4	Osteoporosis Self-Assessment Tool	-	Pt	^Patient	-	Osteoporosis Self-Assessment Tool	PANEL.CLIN.RISK	2	Osteoporosis Self-Assessment Tool	OST	null	ACTIVE	2.71	2.71
98147-2	Total score	Score	Pt	^Patient	Qn	Osteoporosis Self-Assessment Tool	CLIN.RISK	2	Total score Osteoporosis Self-Assessment Tool	Total score OST	null	ACTIVE	2.71	2.71
98148-0	Oxygen saturation	MFr	12H^mean	BldA	Qn	Pulse oximetry	PULM	2	Oxygen saturation in 12 hour mean Arterial blood by Pulse oximetry	SaO2 12h Mean % BldA PulseOx	null	ACTIVE	2.71	2.71
98149-8	Body temperature	Temp	12H^mean	Surface	Qn	null	BDYTMP.MOLEC	2	Body temperature - 12 hour mean Surface	Bdy temp 12h Mean Surface	null	ACTIVE	2.71	2.71
98150-6	Encephalopathy grade	Find	Pt	^Patient	Ord	null	SURVEY.CHILD-PUGH	4	Encephalopathy grade	null	null	ACTIVE	2.71	2.71
98151-4	Degree of ascites	Find	Pt	^Patient	Ord	null	SURVEY.CHILD-PUGH	4	Degree of ascites	null	null	ACTIVE	2.71	2.71
9815-2	Lithium	MCnc	Pt	RBC	Qn	null	DRUG/TOX	1	Lithium [Mass/volume] in Red Blood Cells	Lithium RBC-mCnc	null	ACTIVE	1.0i	2.42
98152-2	Total score	Score	Pt	^Patient	Qn	Child-Pugh	SURVEY.CHILD-PUGH	4	Total score [Child-Pugh]	null	null	ACTIVE	2.71	2.71
98153-0	Child-Pugh panel	-	Pt	^Patient	-	null	PANEL.SURVEY.CHILD-PUGH	4	Child-Pugh panel	null	null	ACTIVE	2.71	2.71
98154-8	SARS-CoV-2-related socioeconomic questionnaire for adults	-	Pt	^Patient	-	null	PANEL.SURVEY.COVID	4	SARS-CoV-2-related socioeconomic questionnaire for adults	null	© 2021 E. Sicuri, I. Lopes, E. Tacconelli, M. Giannella. Used with permission.	ACTIVE	2.71	2.72
98155-5	Number of children under the age of 14 living in household	Num	Pt	^Patient	Qn	null	ADMIN.DEMOG	2	Number of children under the age of 14 living in household	Num household members <14Y	null	ACTIVE	2.71	2.71
98156-3	Routine doctor's visits &or check-ups cancelled since the beginning of the pandemic	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Routine doctor's visits AndOr check-ups cancelled since the beginning of the pandemic	null	null	ACTIVE	2.71	2.71
98157-1	Routine doctor's visits &or check-ups postponed since the beginning of the pandemic	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Routine doctor's visits AndOr check-ups postponed since the beginning of the pandemic	null	null	ACTIVE	2.71	2.71
98158-9	Problems accessing medication since the beginning of the pandemic	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Problems accessing medication since the beginning of the pandemic	null	null	ACTIVE	2.71	2.71
98159-7	Treatment sessions postponed by doctor or patient since the beginning of the pandemic	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Treatment sessions postponed by doctor or patient since the beginning of the pandemic	null	null	ACTIVE	2.71	2.71
9816-0	Actinomyces sp identified	Prid	Pt	XXX	Nom	Organism specific culture	MICRO	1	Actinomyces sp identified in Specimen by Organism specific culture	Actinomyces Spec Cult	null	ACTIVE	1.0i	2.73
98160-5	Treatment sessions cancelled by doctor or patient since the beginning of the pandemic	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Treatment sessions cancelled by doctor or patient since the beginning of the pandemic	null	null	ACTIVE	2.71	2.71
98161-3	Monthly household net income	NRat	Pt	^Patient	Qn	null	ADMIN.PATIENT.DEMOG	2	Monthly household net income	Monthly household net income nRate	null	ACTIVE	2.71	2.71
98162-1	Financial problems since the beginning of the pandemic	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Financial problems since the beginning of the pandemic	null	null	ACTIVE	2.71	2.71
98163-9	Received any financial or material aid since the beginning of the pandemic	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	Received any financial or material aid since the beginning of the pandemic	null	null	ACTIVE	2.71	2.71
98164-7	How often have you recently looked for information on COVID-19	Find	Pt	^Patient	Ord	null	SURVEY.COVID	4	How often have you recently looked for information on COVID-19	null	null	ACTIVE	2.71	2.71
98165-4	What do you think is your current risk of infection or re-infection	Score	Pt	^Patient	Qn	null	SURVEY.COVID	4	What do you think is your current risk of infection or re-infection	null	null	ACTIVE	2.71	2.71

98077-1

Whether the patient previously met the case definition for condition of interest

Find

Pt

^Patient

Ord

null

H&P.HX

2

Whether the patient previously met the case definition for condition of interest

Previous case condition of interest

null

ACTIVE

2.71

98078-9

Difficulty reading or writing

Find

Pt

^Patient

Ord

null

SURVEY.GNHLTH

4

Difficulty reading or writing

null

ACTIVE

2.71

9807-9

Chlordane

MCnc

Pt

Ser/Plas

Qn

null

DRUG/TOX

1

Chlordane [Mass/volume] in Serum or Plasma

Chlordane SerPl-mCnc

null

ACTIVE

1.0i

2.42

98079-7

Do you need any additional assistance or accommodations during your visit

Find

Pt

^Patient

Ord

null

SURVEY.GNHLTH

4

Do you need any additional assistance or accommodations during your visit

null

ACTIVE

2.71

98080-5

SARS coronavirus 2 & SARS-related coronavirus RNA panel

-

Pt

Saliva

-

Probe.amp.tar

PANEL.MICRO

1

SARS-CoV-2 (COVID-19) and SARS-related CoV RNA panel - Saliva (oral fluid) by NAA with probe detection

SARS-CoV-2+SARSr-CoV RNA pnl Sal NAA+prb

null

ACTIVE

2.71

98081-3

Cytomegalovirus DNA

NCnc

Pt

Saliva

Qn

Probe.amp.tar

MICRO

1

Cytomegalovirus DNA [#/volume] (viral load) in Saliva (oral fluid) by NAA with probe detection

CMV DNA # Sal NAA+probe

null

ACTIVE

2.71

98082-1

Specific resistance.airway^pre bronchodilation

FldResist

Stdy^mean

Respiratory system.airway

Qn

Plethysmograph.body box

PULM

2

Specific airway resistance mean by Plethysmograph body box --pre bronchodilation

Spec airway resist pre BD Mean Plethys

null

ACTIVE

2.71

98083-9

Specific resistance.airway^post bronchodilation

FldResist

Stdy^mean

Respiratory system.airway

Qn

Plethysmograph.body box

PULM

2

Specific airway resistance mean by Plethysmograph body box --post bronchodilation

Spec airway resist p BD Mean Plethys

null

ACTIVE

2.71

98084-7

Specific effective resistance.airway

FldResist

Stdy^mean

Respiratory system.airway

Qn

Calculated

PULM

2

Specific effective resistance.airway mean Calculated

sReff Mean Calc

null

ACTIVE

2.71

98085-4

Specific effective resistance.airway^pre bronchodilation

FldResist

Stdy^mean

Respiratory system.airway

Qn

Calculated

PULM

2

Specific effective resistance.airway mean Calculated --pre bronchodilation

sReff pre BD Mean Calc

null

ACTIVE

2.71

98086-2

Specific effective resistance.airway^post bronchodilation

FldResist

Stdy^mean

Respiratory system.airway

Qn

Calculated

PULM

2

Specific effective resistance.airway mean Calculated --post bronchodilation

sReff p BD Mean Calc

null

ACTIVE

2.71

9808-7

Phenothiazines

PrThr

Pt

Gast fld

Ord

null

DRUG/TOX

1

Phenothiazines [Presence] in Gastric fluid

Phenothiaz Gast Ql

null

ACTIVE

1.0i

2.56

98087-0

Specific effective resistance.airway/predicted

RelFldResist

Stdy^mean

Respiratory system.airway

Qn

null

PULM

2

Specific effective resistance.airway/Predicted mean

sReff/Predicted Mean

null

ACTIVE

2.71

98088-8

Vital capacity/Vital capacity.predicted

RelVol

Pt

Respiratory system

Qn

Spirometry

PULM

2

Vital capacity/predicted VC Respiratory system by Spirometry

VC/predicted VC Respiratory Spirometry

null

ACTIVE

2.71

98089-6

Capacity.inspiratory^pre bronchodilation

Vol

Pt

Respiratory system

Qn

Spirometry

PULM

2

Inspiratory capacity by Spirometry --pre bronchodilation

IC pre BD Spirometry

null

ACTIVE

2.71

98090-4

Capacity.inspiratory^post bronchodilation

Vol

Pt

Respiratory system

Qn

Spirometry

PULM

2

Inspiratory capacity by Spirometry --post bronchodilation

IC p BD Spirometry

null

ACTIVE

2.71

98091-2

Diffusion capacity.carbon monoxide^pre bronchodilation

FldConduct

Pt

Respiratory system

Qn

null

PULM

2

Diffusion capacity.carbon monoxide --pre bronchodilation

Diff cap.CO pre BD

null

ACTIVE

2.71

98092-0

Diffusion capacity.carbon monoxide^post bronchodilation

FldConduct

Pt

Respiratory system

Qn

null

PULM

2

Diffusion capacity.carbon monoxide --post bronchodilation

Diff cap.CO p BD

null

ACTIVE

2.71

98093-8

Rowland Universal Dementia Assessment Scale

-

Pt

^Patient

-

RUDAS

PANEL.SURVEY.RUDAS

4

Rowland Universal Dementia Assessment Scale [RUDAS]

null

ACTIVE

2.71

98094-6

Total score

Score

Pt

^Patient

Qn

RUDAS

SURVEY.RUDAS

4

Total score [RUDAS]

null

ACTIVE

2.71

9809-5

Propoxyphene

PrThr

Pt

Gast fld

Ord

null

DRUG/TOX

1

Propoxyphene [Presence] in Gastric fluid

Propoxyph Gast Ql

null

ACTIVE

1.0i

2.56

98095-3

Cells.FOXP3 Ag/100 cells

NFr

Pt

Bld

Qn

null

MICRO

1

Cells.FOXP3 Ag/100 cells in Blood

FOXP3 Ag Bld-NFr

null

ACTIVE

2.71

2.72

98096-1

Interleukin 33

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Interleukin 33 [Mass/volume] in Serum or Plasma

IL-33 SerPl-mCnc

null

ACTIVE

2.71

98097-9

Thymic stromal lymphopoietin

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Thymic stromal lymphopoietin [Mass/volume] in Serum or Plasma

TSLP SerPl-mCnc

null

ACTIVE

2.71

98098-7

Interleukin 17F

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Interleukin 17F [Mass/volume] in Serum or Plasma

IL-17F SerPl-mCnc

null

ACTIVE

2.71

98099-5

Interleukin 21

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Interleukin 21 [Mass/volume] in Serum or Plasma

IL-21 SerPl-mCnc

null

ACTIVE

2.71

98100-1

Interleukin 22

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Interleukin 22 [Mass/volume] in Serum or Plasma

IL-22 SerPl-mCnc

null

ACTIVE

2.71

98101-9

Interleukin 23

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Interleukin 23 [Mass/volume] in Serum or Plasma

IL-23 SerPl-mCnc

null

ACTIVE

2.71

98102-7

Chemokine (C-X-C motif) ligand 10

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Chemokine (C-X-C motif) ligand 10 [Mass/volume] in Serum or Plasma

CXCL10 SerPl-mCnc

null

ACTIVE

2.71

9810-3

quiNINE

PrThr

Pt

Gast fld

Ord

null

DRUG/TOX

1

quiNINE [Presence] in Gastric fluid

quiNINE Gast Ql

null

ACTIVE

1.0i

2.56

98103-5

Interleukin 9

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Interleukin 9 [Mass/volume] in Serum or Plasma

IL-9 SerPl-mCnc

null

ACTIVE

2.71

98104-3

Interleukin 15

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Interleukin 15 [Mass/volume] in Serum or Plasma

IL-15 SerPl-mCnc

null

ACTIVE

2.71

98105-0

Interleukin 16

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Interleukin 16 [Mass/volume] in Serum or Plasma

IL-16 SerPl-mCnc

null

ACTIVE

2.71

98106-8

Brain-derived neurotrophic factor

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Brain-derived neurotrophic factor [Mass/volume] in Serum or Plasma

BDNF SerPl-mCnc

null

ACTIVE

2.71

98107-6

Macrophage colony-stimulating factor

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Macrophage colony-stimulating factor [Mass/volume] in Serum or Plasma

M-CSF SerPl-mCnc

null

ACTIVE

2.71

98108-4

Chemokine (C-C motif) ligand 11

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Chemokine (C-C motif) ligand 11 [Mass/volume] in Serum or Plasma

CCL11 SerPl-mCnc

null

ACTIVE

2.71

98109-2

Chemokine (C-C motif) ligand 8

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Chemokine (C-C motif) ligand 8 [Mass/volume] in Serum or Plasma

CCL8 SerPl-mCnc

null

ACTIVE

2.71

981-1

D little i super little a Ab

PrThr

Pt

Ser/Plas

Ord

null

BLDBK

1

Di sup(a) Ab [Presence] in Serum or Plasma

Di sup(a) Ab SerPl Ql

null

ACTIVE

1.0

2.56

98110-0

Chemokine (C-C motif) ligand 7

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Chemokine (C-C motif) ligand 7 [Mass/volume] in Serum or Plasma

CCL7 SerPl-mCnc

null

ACTIVE

2.71

9811-1

Chromogranin A

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Chromogranin A [Mass/volume] in Serum or Plasma

CgA SerPl-mCnc

null

ACTIVE

1.0i

2.73

98111-8

Chemokine (C-C motif) ligand 4

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Chemokine (C-C motif) ligand 4 [Mass/volume] in Serum or Plasma

CCL4 SerPl-mCnc

null

ACTIVE

2.71

98112-6

Chemokine (C-C motif) ligand 20

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Chemokine (C-C motif) ligand 20 [Mass/volume] in Serum or Plasma

CCL20 SerPl-mCnc

null

ACTIVE

2.71

98113-4

Chemokine (C-C motif) ligand 5

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Chemokine (C-C motif) ligand 5 [Mass/volume] in Serum or Plasma

CCL5 SerPl-mCnc

null

ACTIVE

2.71

98114-2

Chemokine (C-X3-C motif) ligand 1

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Chemokine (C-X3-C motif) ligand 1 [Mass/volume] in Serum or Plasma

CX3CL1 SerPl-mCnc

null

ACTIVE

2.71

98115-9

Chemokine (C-X-C motif) ligand 9

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Chemokine (C-X-C motif) ligand 9 [Mass/volume] in Serum or Plasma

CXCL9 SerPl-mCnc

null

ACTIVE

2.71

98116-7

Chemokine (C-C motif) ligand 27

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Chemokine (C-C motif) ligand 27 [Mass/volume] in Serum or Plasma

CCL27 SerPl-mCnc

null

ACTIVE

2.71

98117-5

Fibroblast growth factor 2

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Fibroblast growth factor 2 [Mass/volume] in Serum or Plasma

FGF2 SerPl-mCnc

null

ACTIVE

2.71

98118-3

Vascular endothelial growth factor C

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Vascular endothelial growth factor C [Mass/volume] in Serum or Plasma

VEGF-C SerPl-mCnc

null

ACTIVE

2.71

98119-1

Angiopoietin 2 receptor

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Angiopoietin receptor 2 [Mass/volume] in Serum or Plasma

Angiopoietin 2 receptor SerPl-mCnc

null

ACTIVE

2.71

98120-9

Intercellular adhesion molecule 1

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Intercellular adhesion molecule 1 [Mass/volume] in Serum or Plasma

ICAM-1 SerPl-mCnc

null

ACTIVE

2.71

98121-7

Protein/Creatinine

PrThr

Pt

Urine

Ord

Test strip

CHEM

1

Protein/Creatinine Qualitative in Urine by Test strip

Prot/Creat Ur Ql Strip

null

ACTIVE

2.71

98122-5

Neutrophil.fMLP & PMA stimulated DHR panel

-

Pt

^Patient

-

Flow cytometry

PANEL.HEM/BC

1

Neutrophil.fMLP and PMA stimulated DHR panel by Flow cytometry (FC)

Neut fMLP + PMA stim DHR Pnl Patient FC

null

ACTIVE

2.71

2.72

98123-3

Neutrophil.fMLP stimulated DHR panel

-

Pt

^Patient

-

Flow cytometry

PANEL.HEM/BC

1

Neutrophil.fMLP stimulated DHR panel by Flow cytometry (FC)

Neut fMLP stim DHR Pnl Patient FC

null

ACTIVE

2.71

98124-1

Neutrophil.PMA stimulated DHR panel

-

Pt

^Patient

-

Flow cytometry

PANEL.HEM/BC

1

Neutrophil.PMA stimulated DHR panel by Flow cytometry (FC)

Neut PMA stim DHR Pnl Patient FC

null

ACTIVE

2.71

2.72

98125-8

Intravascular coagulation and fibrinolysis panel

-

Pt

^Patient

-

null

PANEL.COAG

1

Intravascular coagulation and fibrinolysis panel

Intravascular coag + fibrinolysis Pnl

null

ACTIVE

2.71

98126-6

Zimnitsky urine concentration panel

-

Urine

-

null

PANEL.UA

1

Zimnitsky urine concentration panel - Urine

Zimnitsky Pnl Ur

null

ACTIVE

2.71

98127-4

Normoblasts.oxyphilic+polychromatophilic/Normoblasts.total

NFr

Pt

Bone mar

Qn

Manual count

HEM/BC

1

Normoblasts oxyphilic+polychromatophilic/Normoblasts.total in Bone marrow by Manual count

Oxy+poly normoblasts/Tot NFr Mar Manual

null

ACTIVE

2.71

98128-2

Neutrophils.immature/Neutrophils.segmented

Ratio

Pt

Bone mar

Qn

Manual count

HEM/BC

1

Neutrophils.immature/Neutrophils.segmented [Ratio] in Bone marrow by Manual count

Neut.imm/Neut.segment Mar Manual - Rto

null

ACTIVE

2.71

9812-9

Cortisol^PM trough specimen

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Cortisol [Mass/volume] in Serum or Plasma --PM trough specimen

Cortis PM SerPl-mCnc

null

ACTIVE

1.0i

2.73

98129-0

Thymol turbidity test

Arb

Pt

Bld

Qn

null

CHEM

1

Thymol turbidity test in Blood

Thymol turbidity test Bld

null

ACTIVE

2.71

98130-8

Diffusion capacity.carbon monoxide/predicted

RelFldConduct

Pt

Respiratory system

Qn

null

PULM

2

Diffusion capacity.carbon monoxide/Predicted

Diff cap.CO/Predicted

null

ACTIVE

2.71

98131-6

SARS coronavirus 2 ORF1b region

PrThr

Pt

Respiratory

Ord

Probe.amp.tar

MICRO

1

SARS-CoV-2 (COVID-19) ORF1b region [Presence] in Respiratory specimen by NAA with probe detection

SARS-CoV-2 ORF1b Resp Ql NAA+probe

null

ACTIVE

2.71

98132-4

SARS coronavirus 2 ORF1a region

PrThr

Pt

Respiratory

Ord

Probe.amp.tar

MICRO

1

SARS-CoV-2 (COVID-19) ORF1a region [Presence] in Respiratory specimen by NAA with probe detection

SARS-CoV-2 ORF1a Resp Ql NAA+probe

null

ACTIVE

2.71

98133-2

Osteoporosis Index of Risk panel

-

Pt

^Patient

-

Osteoporosis Index of Risk

PANEL.CLIN.RISK

2

Osteoporosis Index of Risk panel

OSIRIS panel

null

ACTIVE

2.71

98134-0

Estrogen use

Find

Pt

^Patient

Ord

null

H&P.HX

2

Estrogen use

null

ACTIVE

2.71

98135-7

Low impact fracture

Hx

Pt

^Patient

Ord

null

H&P.HX

2

History of Low impact fracture

Hx of Low impact fracture

null

ACTIVE

2.71

98136-5

Total score

Score

Pt

^Patient

Qn

Osteoporosis Index of Risk

CLIN.RISK

2

Total score Osteoporosis Index of Risk

Total score OSIRIS

null

ACTIVE

2.71

9813-7

Cortisol^AM peak specimen

MCnc

Pt

Ser/Plas

Qn

null

CHEM

1

Cortisol [Mass/volume] in Serum or Plasma --AM peak specimen

Cortis AM peak SerPl-mCnc

null

ACTIVE

1.0i

2.73

98137-3

Pain assessment report

Find

Pt

{Setting}

Doc

{Role}

DOC.ONTOLOGY

2

Pain assessment report

Pain assessment Rpt

null

ACTIVE

2.71

98138-1

Amyloid plaques probability score

Score

Pt

^Patient

Qn

Based on clinical+lab data

CLIN.RISK

2

Amyloid plaques probability score based on clinical and lab data

Amyloid plaques score from clin+lab data

null

ACTIVE

2.71

2.72

98139-9

Osteoporosis Risk Assessment Instrument

-

Pt

^Patient

-

Osteoporosis Risk Assessment Instrument

PANEL.CLIN.RISK

2

Osteoporosis Risk Assessment Instrument

ORAI

null

ACTIVE

2.71

98140-7

Total score

Score

Pt

^Patient

Qn

Osteoporosis Risk Assessment Instrument

CLIN.RISK

2

Total score Osteoporosis Risk Assessment Instrument

Total score ORAI

null

ACTIVE

2.71

98141-5

Admission notification note

Find

Pt

Emergency department

Doc

{Role}

DOC.ONTOLOGY

2

Emergency department Admission notification

ED Admission notification

null

ACTIVE

2.71

98142-3

Discharge notification note

Find

Pt

Emergency department

Doc

{Role}

DOC.ONTOLOGY

2

Emergency department Discharge notification

ED Discharge notification

null

ACTIVE

2.71

98143-1

Arrival notification note

Find

Pt

Emergency department

Doc

{Role}

DOC.ONTOLOGY

2

Emergency department Arrival notification

ED Arrival notification

null

ACTIVE

2.71

2.72

98144-9

Departure notification note

Find

Pt

Emergency department

Doc

{Role}

DOC.ONTOLOGY

2

Emergency department Departure notification

ED Departure notification

null

ACTIVE

2.71

2.72

9814-5

Dextroamphetamine

MCnc

Pt

Ser/Plas

Qn

null

DRUG/TOX

1

Dextroamphetamine [Mass/volume] in Serum or Plasma

D-amphet SerPl-mCnc

null

ACTIVE

1.0i

2.73

98145-6

Visit notification note

Find

Pt

Outpatient

Doc

{Role}

DOC.ONTOLOGY

2

Outpatient Visit notification

OP Visit notification

null

ACTIVE

2.71

98146-4

Osteoporosis Self-Assessment Tool

-

Pt

^Patient

-

Osteoporosis Self-Assessment Tool

PANEL.CLIN.RISK

2

Osteoporosis Self-Assessment Tool

OST

null

ACTIVE

2.71

98147-2

Total score

Score

Pt

^Patient

Qn

Osteoporosis Self-Assessment Tool

CLIN.RISK

2

Total score Osteoporosis Self-Assessment Tool

Total score OST

null

ACTIVE

2.71

98148-0

Oxygen saturation

MFr

12H^mean

BldA

Qn

Pulse oximetry

PULM

2

Oxygen saturation in 12 hour mean Arterial blood by Pulse oximetry

SaO2 12h Mean % BldA PulseOx

null

ACTIVE

2.71

98149-8

Body temperature

Temp

12H^mean

Surface

Qn

null

BDYTMP.MOLEC

2

Body temperature - 12 hour mean Surface

Bdy temp 12h Mean Surface

null

ACTIVE

2.71

98150-6

Encephalopathy grade

Find

Pt

^Patient

Ord

null

SURVEY.CHILD-PUGH

4

Encephalopathy grade

null

ACTIVE

2.71

98151-4

Degree of ascites

Find

Pt

^Patient

Ord

null

SURVEY.CHILD-PUGH

4

Degree of ascites

null

ACTIVE

2.71

9815-2

Lithium

MCnc

Pt

RBC

Qn

null

DRUG/TOX

1

Lithium [Mass/volume] in Red Blood Cells

Lithium RBC-mCnc

null

ACTIVE

1.0i

2.42

98152-2

Total score

Score

Pt

^Patient

Qn

Child-Pugh

SURVEY.CHILD-PUGH

4

Total score [Child-Pugh]

null

ACTIVE

2.71

98153-0

Child-Pugh panel

-

Pt

^Patient

-

null

PANEL.SURVEY.CHILD-PUGH

4

Child-Pugh panel

null

ACTIVE

2.71

98154-8

SARS-CoV-2-related socioeconomic questionnaire for adults

-

Pt

^Patient

-

null

PANEL.SURVEY.COVID

4

SARS-CoV-2-related socioeconomic questionnaire for adults

null

ACTIVE

2.71

2.72

98155-5

Number of children under the age of 14 living in household

Num

Pt

^Patient

Qn

null

ADMIN.DEMOG

2

Number of children under the age of 14 living in household

Num household members <14Y

null

ACTIVE

2.71

98156-3

Routine doctor's visits &or check-ups cancelled since the beginning of the pandemic

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Routine doctor's visits AndOr check-ups cancelled since the beginning of the pandemic

null

ACTIVE

2.71

98157-1

Routine doctor's visits &or check-ups postponed since the beginning of the pandemic

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Routine doctor's visits AndOr check-ups postponed since the beginning of the pandemic

null

ACTIVE

2.71

98158-9

Problems accessing medication since the beginning of the pandemic

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Problems accessing medication since the beginning of the pandemic

null

ACTIVE

2.71

98159-7

Treatment sessions postponed by doctor or patient since the beginning of the pandemic

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Treatment sessions postponed by doctor or patient since the beginning of the pandemic

null

ACTIVE

2.71

9816-0

Actinomyces sp identified

Prid

Pt

XXX

Nom

Organism specific culture

MICRO

1

Actinomyces sp identified in Specimen by Organism specific culture

Actinomyces Spec Cult

null

ACTIVE

1.0i

2.73

98160-5

Treatment sessions cancelled by doctor or patient since the beginning of the pandemic

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Treatment sessions cancelled by doctor or patient since the beginning of the pandemic

null

ACTIVE

2.71

98161-3

Monthly household net income

NRat

Pt

^Patient

Qn

null

ADMIN.PATIENT.DEMOG

2

Monthly household net income

Monthly household net income nRate

null

ACTIVE

2.71

98162-1

Financial problems since the beginning of the pandemic

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Financial problems since the beginning of the pandemic

null

ACTIVE

2.71

98163-9

Received any financial or material aid since the beginning of the pandemic

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

Received any financial or material aid since the beginning of the pandemic

null

ACTIVE

2.71

98164-7

How often have you recently looked for information on COVID-19

Find

Pt

^Patient

Ord

null

SURVEY.COVID

4

How often have you recently looked for information on COVID-19

null

ACTIVE

2.71

98165-4

What do you think is your current risk of infection or re-infection

Score

Pt

^Patient

Qn

null

SURVEY.COVID

4

What do you think is your current risk of infection or re-infection

null

ACTIVE

2.71